CVS Health's fourth-quarter earnings nearly doubled, fueled by a $1.5 billion tax benefit that will help the drugstore chain expand its growing role in customer care. It plans on pumping more money into data analytics to help track prescription drug use and monitor patients' blood tests.
American healthcare has reached a tipping point. Look no further for proof than the insiders and outsiders who are linking up to disrupt the long-stagnant, cost-ridden industry that's eating up nearly a fifth of the nation's gross domestic product.
The most mergers ever were recorded in 2017 by financial firm Kaufman Hall, which began tracking deals in 2000. Even with that growth, more financially strong systems are attracting interest in being acquired by a larger or better-positioned system.
CVS Health says it will stop altering images of women in its beauty product marketing because it doesn't want to send messages of unrealistic body images to girls and young women.
Anthem's CEO Gail Boudreaux, FDA Commissioner Dr. Scott Gottlieb and Optum CEO Larry Renfro are among top healthcare leaders who are likely to have a large impact on the industry in 2018.
Half of middle-market healthcare executives say they plan to merge or acquire existing businesses in 2018, setting the stage for another big year of merger and acquisition activity, according to a survey by Capital One Healthcare.
As healthcare spending grows and customers demand more convenient care, insurance companies are teaming up with nontraditional partners to keep patients out of hospitals and emergency rooms. Hospitals will have to evolve to stay afloat.
The architects of major healthcare deals offer a common rationale: The combinations will lower costs and improve care. But these deals don't get to the root of healthcare's cost problems.
By combining, CVS Health and Aetna hope to build a lower-cost, more-convenient model of care with retail clinics at the center.
Aetna will operate as a stand-alone unit within CVS and will be run by the insurer's current management team. The deal would create a healthcare giant with more than $240 billion in annual revenue.
A CVS customer wants to end a federal lawsuit that hit the drugstore chain in a sensitive area: The prices it charges for prescriptions.
The Cherokee Nation claims the companies should have prevented rather than profited from the opioid epidemic and the mass distribution of addictive pain pills.